Assistant professor of pathology Faculty of Medicine Pathology Department 1 2 Cellular Adaptation to Injury A new steady state which lies between normal unstressed cell and the injured overstressed cell in which the cell can function and preserve viability ID: 909146
Download Presentation The PPT/PDF document "Cellular Adaptations Al-Quds University" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Cellular Adaptations
Al-Quds University
Assistant professor of pathology.Faculty of MedicinePathology Department
1
Slide22
Cellular
Adaptation to Injury A new steady state which lies between normal unstressed cell, and the injured overstressed cell, in which the cell can function and preserve viability.
Slide33
1)
Physiological adaptationresponses of cells to normal stimulation by hormones or endogenous chemical mediatorse.g. hormones leading to enlargement of the breast and the uterus during pregnancy
2)
Pathological adaptation
allows the cells to modulate their environment and ideally escape injury
e.g.
hormones produced by tumors leading to endometrial hyperplasia
Cellular Adaptation
Slide44
up- or down-regulation
of specific cellular receptorsreceptor bindingIncrease or decrease of protein synthesisswitch from producing one type of protein to another
Mechanisms of Cellular Adaptation
Slide55
Cellular adaptation
Types of adaptive responses:Atrophy - decrease in cell sizeHypertrophy - increase in cell sizeHyperplasia
- increase in cell numberMetaplasia - change in cell type
Others:
aplasia
,
hypoplasia
Slide66
necrosis
reversible
irreversible
cell injury
adaptation
hypertrophy
hyperplasia
metaplasia
dysplasia
normal bronchial epithelial cell
atrophy
Cellular Adaptation to stress
Slide77
Atrophy
Shrinkage in the size of the cell by loss of cell substances, leading to diminished function of the cell and a new equilibrium is reached.Accompanied by decrease in the organ size, if sufficient number of cells is involved.
The cells are not dead
Slide88
Causes of Atrophy
1) Physiological:thymic involution, agingloss of hormonal stimuli (menopause
)2) Pathological:
decrease work load
(immobilization of a limb to permit healing of a fracture)
loss of innervation (
Denervation atrophy
)
diminished blood supply (
ischemic atrophy
)
inadequate nutrition
Slide99
A
, Atrophy of the brain in an 82-year-old male with atherosclerotic disease. Atrophy of the brain is due to aging and reduced blood supply. The meninges have been stripped. B, Normal brain of a 25-yr-old male. Note that loss of brain substance narrows the gyri and widens the sulci
Slide1010
These kidneys are from a patient who had atherosclerotic stenosis of one renal artery
Normal
Slide1111
Mechanisms of Atrophy
Imbalance between protein synthesis and degradation is the fundamental step, leading to reduction in structural components. Decreased synthesis, increased catabolism, or boththe fundamental cellular changes are identical in physiological and pathological causes.Sometimes the number of cells can be reduced by the process
apoptosis
Slide1212
Atrophy:
increase catabolismProteolytic systems for degradation:1) Lysosomes contain hydrolases and other enzymesdegrade exogenous proteins
engulfed by endocytosis degrade subcellular components (e.g. organelles) leading to the formation of autophagic vacuoles
Slide1313
2) The ubiquitin-proteasome pathway:
Degradation of cytosolic and nuclear proteins
Responsible for the accelerated proteolysis in hypercatabolic states (e.g. cancer)
The protein/ubiquitin complexes are engulfed by the cytoplasmic
proteasome
An abundant protein found in normal cells.
It has a role in
removing old or damaged proteins
by acting as a cofactor for proteolysis.
Proteasomes
: non lysosomal proteinases.
Ubiquitin:
Slide1414
The ubiquitin-proteasome pathway:
Slide15Hypertrophy
Increase in the size of cells by an increase in the number and density of the cellular substances, leading to an over all
increase in the size and the function of the organ, and a new equilibrium is reached.Mainly occurs in organs composed of cells that can’t divide (cardiac & skeletal muscles).NO NEW CELLS, JUST BIGGER CELLS
15
Slide16Causes of Hypertrophy:
Physiological or pathological:Increase in functional demand or work load
e.g. body building, hypertension, aortic valve disease Increase in hormonal stimulation. This involves both hypertrophy and hyperplasia and both result in an enlarged (hypertrophic) organ.e.g. the gravid uterus occurs as a consequence of estrogen stimulation of both smooth muscle hypertrophy and smooth muscle hyperplasia
16
Slide17Mechanisms of Hypertrophy
an increased synthesis of structural proteins and organelles leading to an overall increase in the workload of the organ.
17
Slide18hypertrophy after myocardial infarction
The mechanisms of cardiac hypertrophy:
mechanical triggers, such as stretchtrophic triggers, such as activation of α-adrenergic receptors
18
Slide19Hypertrophy in hypertension
Adaptive changes may not be completely benign; they can also result in a dramatic change in the cellular phenotype:
Reactivation of certain genes. Switch of contractile proteins to a different type. Degenerative changes overtime leading to failure of organ19
Slide20Skeletal muscle hypertrophy in body building:
20
Slide21Hyperplasia
an increase in the size of the organ due to
increase in the number of the cells in the organ, leading to increase in the function.SEEN IN CELLS THAT CAN DIVIDE21
Slide2222
Gravid uterus
Hyperplasia
Slide23Causes of Hyperplasia:
Physiological:
hormonal hyperplasia (e.g. female breast at puberty and during pregnancy)compensatory hyperplasia: occurs when a portion of the tissue is removed or diseased which is under the influence of growth factors (e.g. liver resection, wound healing)Pathological:Under the effect of hormones or growth factors. (e.g. Endometrial hyperplasia
, skin wart)
23
Slide24Hyperplasia
Both hypertrophy and hyperplasia are reversible, if the stimulus is removed.
This differentiates these processes from cancer, in which cells continue to grow despite the absence of hormonal stimuli. pathologic hyperplasia constitutes a fertile soil in which cancerous proliferation may eventually arise. e.g. patients with hyperplasia of the endometrium are at increased risk of developing endometrial cancere.g. papillomavirus infections predispose to cervical cancers
24
Slide25Hypertrophy & hyperplasia
Summary
25
Slide26Metaplasia
Replacement of one type of adult cell, whether epithelial or mesenchymal,
by another type of adult cell aiming at replacing cells that are sensitive to certain stimuli by a more resistant cell type.This happens through reprogramming of stem cells or undifferentiated mesenchymal cells.the influences that induce metaplastic transformation, if persistent, may induce cancer transformation in the metaplastic epithelium
26
Slide27Examples of Metaplasia
(respiratory epithelium)
27
Slide28Metaplastic transformation of esophageal stratified squamous epithelium
(left)
to mature columnarepithelium (so-called Barrett metaplasia)
28